TTR and cardiomyopathy: This suggests that Val30Met TTR may disrupt the normal function of endothelial cells, potentially contributing to vascular complications in affected patients (Table 6).159 In another study, primary human aortic endothelial cells (HAECs) were exposed to plasma from ATTRwt cardiomyopathy patients, with and without Tafamidis treatment.